Clinical Trials for Medivation

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Medivation

Clinical Trials (6)

NCT03246347
A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer
PHASE2Active, not recruiting
40 participants
Started: Aug 23, 2017 · Completed: Mar 31, 2028
2 conditions3 sponsors1 location
NCT02750358
Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
PHASE2Active, not recruiting
50 participants
Started: May 19, 2016 · Completed: May 31, 2026
3 conditions3 sponsors12 locations
NCT02319837
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
PHASE3Active, not recruiting
1,068 participants
Started: Dec 17, 2014 · Completed: Sep 19, 2026
3 conditions3 sponsors247 locations
NCT01990196
Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer
PHASE2Active, not recruiting
45 participants
Started: Sep 23, 2014 · Completed: Sep 30, 2026
1 condition6 sponsors1 location
NCT02023463
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
PHASE1Active, not recruiting
25 participants
Started: Apr 2, 2014 · Completed: Jan 1, 2040
5 conditions3 sponsors1 location
NCT02003924
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
PHASE3Active, not recruiting
1,401 participants
Started: Oct 31, 2013 · Completed: Oct 31, 2025
3 conditions3 sponsors397 locations